ANTIMICROBIAL STEWARDSHIP IN NEONATAL AND PEDIATRIC CARE: BALANCING INFECTION CONTROL AND RESISTANCE
International Journal of Drug Delivery Technology · 19.06.2026 · 16 (56s)
DOI: 10.25258/ijddt.16.56s.52 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.06.2026. Verfasst von BENU MOIRANGTHEM und 2 weiteren Autor:innen.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Antimicrobial stewardship (AMS) has become a cornerstone of modern neonatal and pediatric healthcare due to the increasing prevalence of antimicrobial resistance (AMR) and the widespread use of antibiotics in hospitalized children and neonates. Neonates admitted to neonatal intensive care units (NICUs) and critically ill pediatric patients frequently receive empirical broad-spectrum antibiotics because of the high risk of sepsis and the often non-specific clinical presentation of infections. However, unnecessary or prolonged antimicrobial exposure contributes to the emergence of multidrug-resistant organisms, disruption of the developing microbiome, increased healthcare costs, and adverse clinical outcomes. AMS programs aim to optimize antimicrobial therapy through evidence-based prescribing, appropriate drug selection, dosage optimization, timely de-escalation, and limitation of treatment duration. Recent advances, including rapid molecular diagnostics, antimicrobial surveillance systems, electronic decision-support tools, and biomarker-guided therapy, have improved the ability to distinguish bacterial infections from non-infectious conditions and facilitate rational antibiotic use. Effective stewardship requires multidisciplinary collaboration among pediatricians, neonatologists, microbiologists, pharmacists, infection-control specialists, and nursing staff. This review summarizes the principles of antimicrobial stewardship in neonatal and pediatric settings, discusses current resistance patterns, highlights rational prescribing strategies, and explores emerging technologies and future directions that may enhance infection management while minimizing antimicrobial resistance.
Zitieren
APA
MOIRANGTHEM, B., PRASAD, S., & GUPTA, A. (2026). ANTIMICROBIAL STEWARDSHIP IN NEONATAL AND PEDIATRIC CARE: BALANCING INFECTION CONTROL AND RESISTANCE. International Journal of Drug Delivery Technology, 16(56s). https://doi.org/10.25258/ijddt.16.56s.52
Vancouver
MOIRANGTHEM B, PRASAD S, GUPTA A. ANTIMICROBIAL STEWARDSHIP IN NEONATAL AND PEDIATRIC CARE: BALANCING INFECTION CONTROL AND RESISTANCE. International Journal of Drug Delivery Technology. 2026;16(56s). doi:10.25258/ijddt.16.56s.52
BibTeX
@article{MOIRANGTHEM2026,
author = {MOIRANGTHEM, BENU and PRASAD, S.S and GUPTA, ADITI},
title = {ANTIMICROBIAL STEWARDSHIP IN NEONATAL AND PEDIATRIC CARE: BALANCING INFECTION CONTROL AND RESISTANCE},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {56s},
doi = {10.25258/ijddt.16.56s.52}
}
EUVIMED